A review of 145 opioid policy evaluation studies found that greater adoption of more rigorous study designs and statistical methods is warranted.
States have implemented multiple strategies to enhance the capacity and quality of treatment services for opioid use disorder.
Instead of just short-term substitution from prescription opioid to heroin overdoses, the transition to illicit markets spurred by reformulation led to growth in the overall overdose rate to unprecedented levels.
How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D
The researchers find a 10% increase in opioid medical supply leads to a 7.1% increase in opioid-related deaths among the Medicare-ineligible population.
Director of Data and Analytics, USC Schaeffer Center
Fellow, USC Schaeffer Center
Assistant Professor, Division of Emergency Medicine Research, Keck School of Medicine of USC
Senior Health Policy Project Associate, USC Schaeffer Center
Director, Keck-Schaeffer Initiative for Population Health Policy
Senior Fellow, USC Schaeffer Center
Associate Professor, Department of Pharmaceutical and Health Economics, USC School of Pharmacy
Director of Graduate Studies, Pharmaceutical Economics and Policy Program, USC School of Pharmacy
The COVID-19 pandemic is adversely affecting efforts to control substance abuse according to Assistant Secretary of Health Admiral Brett P. Giroir, MD, who spoke with Rosalie Liccardo Pacula and Adam Leventhal.Read Full Story